Industry: Service & Software
Published Date: 2025-03-19
Pages: 97 Pages
Report ld: 4682503
Request Sample
Customized Report
Antibody Services Market Size(US$)

CAGR 2025-2031
9.4%
Market Size,2031
USD 4,462
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Antibody Services market size was US$ 2400 million in 2024 and is forecast to a readjusted size of US$ 4462 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
Thermo Fisher ranks the first in terms of revenue share in global market of Antibody Services, occupies 18% of the global market share. While, Covance, with a market share of 14%, comes the second. All the other manufacturers which are not included in the report together consist of approximately 46% of the global market.
North America ranks the top in terms of market size of Antibody Services, which alone consists of 40% of the global market. Europe comes the second, with 31% of the global market. Asia Pacific ranks the third, consists of about 18% of the global antibody service market in the same year. All the other regions combined occupy only 8% of the global Antibody Service market.
The global Antibody Services market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Antibody Services market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Polyclonal in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., BioScience Research Institutions in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Antibody Services value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal
1.2.3 Polyclonal
1.2.4 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 BioScience Companies
1.3.3 BioScience Research Institutions
1.3.4 Hospitals
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Services Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Antibody Services Revenue Market Share by Region (2020-2025)
2.4 Global Antibody Services Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Antibody Services Market Size and Prospective (2020-2031)
2.5.2 Europe Antibody Services Market Size and Prospective (2020-2031)
2.5.3 China Antibody Services Market Size and Prospective (2020-2031)
2.5.4 Japan Antibody Services Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Antibody Services Market Size and Prospective (2020-2031)
2.5.6 India Antibody Services Market Size and Prospective (2020-2031)
2.5.7 Central & South America Antibody Services Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Antibody Services Historic Market Size by Type (2020-2025)
3.2 Global Antibody Services Forecasted Market Size by Type (2026-2031)
3.3 Different Types Antibody Services Representative Players
4 Breakdown Data by Application
4.1 Global Antibody Services Historic Market Size by Application (2020-2025)
4.2 Global Antibody Services Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Antibody Services Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Antibody Services Players by Revenue (2020-2025)
5.1.2 Global Antibody Services Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Antibody Services Revenue
5.4 Global Antibody Services Market Concentration Analysis
5.4.1 Global Antibody Services Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Antibody Services Revenue in 2024
5.5 Global Key Players of Antibody Services Head office and Area Served
5.6 Global Key Players of Antibody Services, Product and Application
5.7 Global Key Players of Antibody Services, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Antibody Services Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Antibody Services Market Size by Type (2020-2025)
6.1.2.2 North America Antibody Services Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Antibody Services Market Size by Application (2020-2025)
6.1.3.2 North America Antibody Services Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Antibody Services Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Antibody Services Market Size by Type (2020-2025)
6.2.2.2 Europe Antibody Services Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Antibody Services Market Size by Application (2020-2025)
6.2.3.2 Europe Antibody Services Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Antibody Services Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Antibody Services Market Size by Type (2020-2025)
6.3.2.2 China Antibody Services Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Antibody Services Market Size by Application (2020-2025)
6.3.3.2 China Antibody Services Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Antibody Services Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Antibody Services Market Size by Type (2020-2025)
6.4.2.2 Japan Antibody Services Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Antibody Services Market Size by Application (2020-2025)
6.4.3.2 Japan Antibody Services Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Antibody Services Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Antibody Services Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Antibody Services Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Antibody Services Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Antibody Services Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Antibody Services Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Antibody Services Market Size by Type (2020-2025)
6.6.2.2 India Antibody Services Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Antibody Services Market Size by Application (2020-2025)
6.6.3.2 India Antibody Services Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 ThermoFisher
7.1.1 ThermoFisher Company Details
7.1.2 ThermoFisher Business Overview
7.1.3 ThermoFisher Antibody Services Introduction
7.1.4 ThermoFisher Revenue in Antibody Services Business (2020-2025)
7.1.5 ThermoFisher Recent Development
7.2 GenScript
7.2.1 GenScript Company Details
7.2.2 GenScript Business Overview
7.2.3 GenScript Antibody Services Introduction
7.2.4 GenScript Revenue in Antibody Services Business (2020-2025)
7.2.5 GenScript Recent Development
7.3 Abcam
7.3.1 Abcam Company Details
7.3.2 Abcam Business Overview
7.3.3 Abcam Antibody Services Introduction
7.3.4 Abcam Revenue in Antibody Services Business (2020-2025)
7.3.5 Abcam Recent Development
7.4 MBS
7.4.1 MBS Company Details
7.4.2 MBS Business Overview
7.4.3 MBS Antibody Services Introduction
7.4.4 MBS Revenue in Antibody Services Business (2020-2025)
7.4.5 MBS Recent Development
7.5 ROCKLAND
7.5.1 ROCKLAND Company Details
7.5.2 ROCKLAND Business Overview
7.5.3 ROCKLAND Antibody Services Introduction
7.5.4 ROCKLAND Revenue in Antibody Services Business (2020-2025)
7.5.5 ROCKLAND Recent Development
7.6 ProSci
7.6.1 ProSci Company Details
7.6.2 ProSci Business Overview
7.6.3 ProSci Antibody Services Introduction
7.6.4 ProSci Revenue in Antibody Services Business (2020-2025)
7.6.5 ProSci Recent Development
7.7 Anaspec
7.7.1 Anaspec Company Details
7.7.2 Anaspec Business Overview
7.7.3 Anaspec Antibody Services Introduction
7.7.4 Anaspec Revenue in Antibody Services Business (2020-2025)
7.7.5 Anaspec Recent Development
7.8 Bio-Rad
7.8.1 Bio-Rad Company Details
7.8.2 Bio-Rad Business Overview
7.8.3 Bio-Rad Antibody Services Introduction
7.8.4 Bio-Rad Revenue in Antibody Services Business (2020-2025)
7.8.5 Bio-Rad Recent Development
7.9 Covance
7.9.1 Covance Company Details
7.9.2 Covance Business Overview
7.9.3 Covance Antibody Services Introduction
7.9.4 Covance Revenue in Antibody Services Business (2020-2025)
7.9.5 Covance Recent Development
7.10 Capra Science
7.10.1 Capra Science Company Details
7.10.2 Capra Science Business Overview
7.10.3 Capra Science Antibody Services Introduction
7.10.4 Capra Science Revenue in Antibody Services Business (2020-2025)
7.10.5 Capra Science Recent Development
7.11 Innovagen
7.11.1 Innovagen Company Details
7.11.2 Innovagen Business Overview
7.11.3 Innovagen Antibody Services Introduction
7.11.4 Innovagen Revenue in Antibody Services Business (2020-2025)
7.11.5 Innovagen Recent Development
7.12 APS
7.12.1 APS Company Details
7.12.2 APS Business Overview
7.12.3 APS Antibody Services Introduction
7.12.4 APS Revenue in Antibody Services Business (2020-2025)
7.12.5 APS Recent Development
7.13 Randox
7.13.1 Randox Company Details
7.13.2 Randox Business Overview
7.13.3 Randox Antibody Services Introduction
7.13.4 Randox Revenue in Antibody Services Business (2020-2025)
7.13.5 Randox Recent Development
7.14 GL Biochem
7.14.1 GL Biochem Company Details
7.14.2 GL Biochem Business Overview
7.14.3 GL Biochem Antibody Services Introduction
7.14.4 GL Biochem Revenue in Antibody Services Business (2020-2025)
7.14.5 GL Biochem Recent Development
7.15 Abgent
7.15.1 Abgent Company Details
7.15.2 Abgent Business Overview
7.15.3 Abgent Antibody Services Introduction
7.15.4 Abgent Revenue in Antibody Services Business (2020-2025)
7.15.5 Abgent Recent Development
8 Antibody Services Market Dynamics
8.1 Antibody Services Industry Trends
8.2 Antibody Services Market Drivers
8.3 Antibody Services Market Challenges
8.4 Antibody Services Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Antibody Services market is projected to grow from US$ 2603 million in 2025 to US$ 4839 million by 2032, at a CAGR of 9.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-08-13
Pages: 195
USD 4900.00
(Single User License)
The global Antibody Services market size was US$ 2603 million in 2025 and is forecast to reach a readjusted size of US$ 4839 million by 2032 with a CAGR of 9.4% during the forecast period 2026-2032.
Published Date: 2026-08-13
Pages: 190
USD 4250.00
(Single User License)
The global Antibody Services market was valued at US$ 2603 million in 2025 and is anticipated to reach US$ 4839 million by 2032, at a CAGR of 9.4% from 2026 to 2032.
Published Date: 2026-08-13
Pages: 185
USD 2900.00
(Single User License)
The global market for Antibody Services was estimated to be worth US$ 2603 million in 2025 and is projected to reach US$ 4839 million, growing at a CAGR of 9.4% from 2026 to 2032.
Published Date: 2026-08-13
Pages: 191
USD 3950.00
(Single User License)
The global Antibody Services market is projected to grow from US$ 2400 million in 2024 to US$ 4462 million by 2031, at a CAGR of 9.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 141
USD 4900.00
(Single User License)
In 2024, the global market size of Antibody Services was estimated to be worth US$ 2400 million and is forecast to reach approximately US$ 4462 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 143
USD 5900.00
(Single User License)
The global market for Antibody Services was estimated to be worth US$ 2400 million in 2024 and is forecast to a readjusted size of US$ 4462 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 120
USD 3950.00
(Single User License)
The global market for Antibody Services was valued at US$ 2400 million in the year 2024 and is projected to reach a revised size of US$ 4462 million by 2031, growing at a CAGR of 9.4% during the forecast period.
Published Date: 2025-01-16
Pages: 82
USD 2900.00
(Single User License)
Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
Published Date: 2024-04-17
Pages: 180
USD 5600.00
(Single User License)
Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
Published Date: 2024-04-16
Pages: 172
USD 5900.00
(Single User License)
The global Antibody Services market is projected to grow from US$ 2603 million in 2025 to US$ 4839 million by 2032, at a CAGR of 9.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-08-13
Pages: 195
The global Antibody Services market size was US$ 2603 million in 2025 and is forecast to reach a readjusted size of US$ 4839 million by 2032 with a CAGR of 9.4% during the forecast period 2026-2032.
Published: 2026-08-13
Pages: 190
The global Antibody Services market was valued at US$ 2603 million in 2025 and is anticipated to reach US$ 4839 million by 2032, at a CAGR of 9.4% from 2026 to 2032.
Published: 2026-08-13
Pages: 185
The global market for Antibody Services was estimated to be worth US$ 2603 million in 2025 and is projected to reach US$ 4839 million, growing at a CAGR of 9.4% from 2026 to 2032.
Published: 2026-08-13
Pages: 191
The global Antibody Services market is projected to grow from US$ 2400 million in 2024 to US$ 4462 million by 2031, at a CAGR of 9.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 141
In 2024, the global market size of Antibody Services was estimated to be worth US$ 2400 million and is forecast to reach approximately US$ 4462 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 143
The global market for Antibody Services was estimated to be worth US$ 2400 million in 2024 and is forecast to a readjusted size of US$ 4462 million by 2031 with a CAGR of 9.4% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 120
The global market for Antibody Services was valued at US$ 2400 million in the year 2024 and is projected to reach a revised size of US$ 4462 million by 2031, growing at a CAGR of 9.4% during the forecast period.
Published: 2025-01-16
Pages: 82
Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
Published: 2024-04-17
Pages: 180
Antibody services include competitively priced packages and purification options for antibody production. Service Providers offer support for different types and steps of antibody production—from peptide design, synthesis, and carrier protein conjugation to animal immunization, serum collection, or hybridoma fusion, titer analysis, and final antibody purification. They also immunize with recombinant proteins or protein fragments provided by the customers(or expressed and purified in labs using cDNAs from the service providers’ extensive in-house genomics library) to generate antibodies in rabbits, chickens, goats, guinea pigs, mice, or rats.
Published: 2024-04-16
Pages: 172
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now